UBS Group’s Bruush Oral Care Inc. Common Stock BRSH Stock Holding History

UBS Group’s Portfolio BRSH Stock Details BRSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-48,883	Closed	-$2.54K	–	10327
2024 Q1	$2.54K	Buy	48,883 +42,361	+650%	+$3.77K	﹤0.01%	7880
2023 Q4	$848	Buy	6,522 +6,407	+5,571%	+$2.35K	﹤0.01%	8497
2023 Q3	$132	Buy	115 +107	+1,338%	+$346	﹤0.01%	8819
2023 Q2	$47	Sell	8 -256	-97%	-$1.82K	﹤0.01%	8609
2023 Q1	$1.72K	Sell	264 -449	-63%	-$4.32K	﹤0.01%	8664
2022 Q4	$8.38K	Buy	713 +586	+461%	+$12.4K	﹤0.01%	8780
2022 Q3	$3K	Buy	+127	New	+$5.37K	﹤0.01%	9618

Other funds holding BRSH

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group's BRSH Position: Q2 2024 in Review

UBS Group sold out of Bruush Oral Care Inc. Common Stock (BRSH) in Q2 2024, closing a stake of 48,883 shares — an estimated $2.54K sold.

UBS Group first reported a position in BRSH in Q3 2022 and held it in 7 quarters. The position peaked at $8.38K in Q4 2022. 2 funds tracked by Wall St. Rank hold BRSH as of Q2 2024.

UBS Group reported no remaining Bruush Oral Care Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
UBS Group sold 48,883 Bruush Oral Care Inc. Common Stock shares in Q2 2024, an estimated $2.54K.
UBS Group first reported a position in Bruush Oral Care Inc. Common Stock in Q3 2022 and held it in 7 quarters.
UBS Group's Bruush Oral Care Inc. Common Stock position peaked at $8.38K in Q4 2022.
2 funds tracked by Wall St. Rank held Bruush Oral Care Inc. Common Stock as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.